The trained RFs were tested on the DepMap data and resulted in F1 scores of 0.57 for both CDKN2A and RB1, and 0.79 for TP53. These results are encouraging given the substantial difference between training and testing tumour types, including the presence of childhood cancers in DepMap not seen during training. The gene discussed is CDKN2A; the disease is childhood malignant neoplasm.